SFG
LGND icon

Steward Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History

Steward Financial Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+3
New +$197 ﹤0.01% 1447
2023
Q2 		– Sell
-6
Closed – – 761
2023
Q1 		$0 Buy
6
+3
+100% +$213 ﹤0.01% 827
2022
Q4 		$0 Buy
+3
New +$195 ﹤0.01% 691
2022
Q3 		– Sell
-5
Closed – – 762
2022
Q2 		$0 Buy
+5
New +$284 ﹤0.01% 1187

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Financial Group's LGND Position: Q3 2023 in Review

Steward Financial Group opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2023: 3 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1447 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in LGND as recently as Q1 2023.

Steward Financial Group first reported a position in LGND in Q2 2022 and has held it in 4 quarters since. 196 funds tracked by Wall St. Rank hold LGND as of Q3 2023.

  • Steward Financial Group held 3 shares of Ligand Pharmaceuticals worth $0 as of Q3 2023.
  • Ligand Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Ligand Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1447 holding.
  • Steward Financial Group first reported a position in Ligand Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • 196 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.